Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. (TRVI) is a publicly traded company in the Unknown sector. Across all available filings, 37 corporate insiders have executed 174 transactions totaling $384.8M, demonstrating a bullish sentiment with $377.9M in net insider flow. The most recent transaction on Jan 8, 2026 involved a transaction of 375,000 shares valued at $0.
TRVI Insider Activity Summary
Who Is Buying TRVI Stock?
No significant insider buying has been recorded for TRVI in the recent period.
Who Is Selling TRVI Stock?
No significant insider selling has been recorded for TRVI in the recent period.
Is Trevi Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TRVI is bullish with an Insider Alignment Score of 99/100 and a net flow of $377.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TRVI Frequently Asked Questions
Understanding TRVI Insider Activity
Insider trading at Trevi Therapeutics, Inc. (TRVI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 37 insiders are actively trading TRVI stock, having executed 174 transactions in the past 90 days. The most active insider is Ali Behbahani (Executive), who has made 8 transactions totaling $31.8M.
Related Tools
Track Trevi Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TRVI file new Form 4 transactions